CILCARE, a pioneering name in the field of auditory sciences, has successfully raised $40 million to further its mission of revolutionizing hearing care through innovative diagnostic and treatment solutions. This significant funding will enable CILCARE to advance its research and development initiatives aimed at harnessing the untapped potential of auditory measurements for the early detection of chronic health conditions. With a keen focus on the intricate relationship between hearing and overall health, CILCARE is strategically positioned at the intersection of biotechnology and preventive medicine. The funds will primarily be allocated towards expanding CILCARE's proprietary drug candidate portfolio and strengthening partnerships within the health and life-sciences sector. These partnerships are critical for the development of new therapies that address a spectrum of auditory-related diseases, including inherited hearing loss, synaptopathy, and tinnitus—a condition that adds substantial challenges to millions worldwide. Moreover, CILCARE's groundbreaking work in Auditory Analytics aims to establish hearing as a vital component of global healthcare monitoring, leveraging digital auditory signatures to identify diverse hearing impairments with precision. As awareness of the links between hearing health and other chronic conditions continues to grow, CILCARE stands at the forefront of this movement, committed to improving diagnosis and treatment pathways for patients. The latest funding marks a transformative step towards realizing the vision of an enhanced, integrated approach to health care that encompasses auditory health as a key indicator of overall well-being.
CILCARE Secures $40 Million in Series A Funding to Empower Future of Auditory Healthcare Innovations
Recently funded · €40.0M Series aHealthcare
Get the full Cilcare company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
